Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Herantis Pharma's Manager's Transactions


Posted on: 10 Nov 17

Herantis Pharma's Manager's Transactions

Herantis Pharma Plc
Company release 10 Nov 2017 at 9:00 am

Herantis Pharma Oyj - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Simula, Pekka

Position: Chief Executive Officer

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20171109211640_5

____________________________________________

Transaction date: 2017-11-09

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: SUBSCRIPTION

Transaction Details

(1): Volume: 7500 Unit price: 5.85000 EUR

Aggregated transactions

(1): Volume: 7500 Volume weighted average price: 5.85000 EUR

____________________________________________

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 246

Distribution:

Nasdaq Helsinki
Main media
www.herantis.com

GlobeNewswire
globenewswire.com

Last updated on: 11/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.